Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
PUT
Recursion Pharmaceuticals
RXRX
$1.69B
| $8.85M | ﹤0.01% |
1,308,844
+752,144
| +135% | +$5.06M |
|
3102
PUT
Credo Technology Group
CRDO
$48.5B
| $8.84M | ﹤0.01% |
131,600
+66,200
| +101% | +$3.29M |
|
3103
iShares US Medical Devices ETF
IHI
$3.46B
| $8.84M | ﹤0.01% |
151,512
+115,747
| +324% | +$6.88M |
|
3104
CALL
New Fortress Energy
NFE
$92.6M
| $8.83M | ﹤0.01% |
583,900
-124,200
| -18% | -$1.29M |
|
|
ETHU
3105
PUT
2x Ether ETF
ETHU
$712M
| $8.83M | ﹤0.01% |
56,590
+52,295
| +1,218% | +$7.84M |
|
|
NNE
3106
CALL
Nano Nuclear Energy
NNE
$1.06B
| $8.82M | ﹤0.01% |
+354,300
| New | +$8.04M |
|
3107
CALL
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$228M
| $8.82M | ﹤0.01% |
276,200
+237,800
| +619% | +$9.24M |
|
3108
PUT
Rambus
RMBS
$10.9B
| $8.81M | ﹤0.01% |
166,700
+35,300
| +27% | +$1.8M |
|
3109
United States Oil Fund
USO
$1.79B
| $8.8M | ﹤0.01% |
+116,509
| New | +$8.52M |
|
|
OKUR
3110
OnKure Therapeutics
OKUR
$162M
| $8.78M | ﹤0.01% |
1,074,314
+1,065,023
| +11,463% | +$16.1M |
|
|
PINC
3111
DELISTED
Premier
PINC
| $8.78M | ﹤0.01% |
414,047
-4,704
| -1% | -$99.8K |
|
3112
PUT
CNX Resources
CNX
$5.28B
| $8.78M | ﹤0.01% |
239,300
+186,700
| +355% | +$6.88M |
|
3113
PUT
Diageo
DEO
$53.1B
| $8.77M | ﹤0.01% |
69,000
+12,900
| +23% | +$1.64M |
|
|
DQ
3114
Daqo New Energy
DQ
$991M
| $8.76M | ﹤0.01% |
450,681
-78,023
| -15% | -$1.59M |
|
3115
CALL
Blackstone Mortgage Trust
BXMT
$2.44B
| $8.75M | ﹤0.01% |
502,700
-180,900
| -26% | -$3.34M |
|
|
SERV
3116
PUT
Serve Robotics
SERV
$433M
| $8.75M | ﹤0.01% |
648,200
+375,300
| +138% | +$3.94M |
|
3117
PUT
Charles River Laboratories
CRL
$13.4B
| $8.75M | ﹤0.01% |
47,400
+8,400
| +22% | +$1.62M |
|
3118
PUT
Viatris
VTRS
$18.6B
| $8.74M | ﹤0.01% |
702,100
+220,800
| +46% | +$2.71M |
|
|
FYBR
3119
PUT
DELISTED
Frontier Communications
FYBR
| $8.73M | ﹤0.01% |
251,700
-31,500
| -11% | -$1.1M |
|
3120
CALL
Red Cat Holdings
RCAT
$1.7B
| $8.73M | ﹤0.01% |
679,600
+678,200
| +48,443% | +$4.14M |
|
3121
PUT
KeyCorp
KEY
$25B
| $8.72M | ﹤0.01% |
508,600
+58,000
| +13% | +$1.04M |
|
3122
Hamilton Lane
HLNE
$5.74B
| $8.72M | ﹤0.01% |
58,869
-440,365
| -88% | -$78.5M |
|
3123
PUT
Procore
PCOR
$9.09B
| $8.71M | ﹤0.01% |
116,300
+85,600
| +279% | +$6.07M |
|
|
PDS
3124
Precision Drilling
PDS
$1.09B
| $8.71M | ﹤0.01% |
142,576
+60,043
| +73% | +$3.68M |
|
|
SF
3125
Stifel
SF
$12.9B
| $8.7M | ﹤0.01% |
122,963
+52,539
| +75% | +$3.75M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.